WHO Foundation and Novo Nordisk have launched a collaboration in India to tackle childhood obesity through a school-based health program. The initiative will promote healthier lifestyles, early screening, and stronger health systems for children.
BPL Medical Technologies has launched advanced bone mineral density diagnostic systems in India and Dubai after acquiring YozmaBMtech, expanding its capabilities in osteoporosis screening, imaging technology, and preventive healthcare.
Shilpa Biologicals and partner mAbTree Biologics AG secured FDA Orphan Drug Designation for a novel monoclonal antibody targeting Essential Thrombocythemia and Polycythemia Vera, marking a key step toward new treatments for rare blood cancers.
Zydus Lifesciences has launched Diasens and GlucoLive, its new AI-powered continuous glucose monitoring devices. The system streams real-time glucose data to smartphones and connects patients, caregivers, and doctors through the GoodFlip digital care
Roche Pharma India and the Punjab government launched NeuroSakhi, a patient support initiative for women with multiple sclerosis, aiming to improve early diagnosis, care pathways, and long-term treatment access.
Pfizer reported encouraging Phase 2 results for tilrekimig, a trispecific antibody for moderate to severe atopic dermatitis. The drug improved EASI-75 response rates and showed strong efficacy with monthly dosing.
Merck and Cyto-Facto sign an MoU to accelerate cell and gene therapy manufacturing in APAC, focusing on Japan and India, with a goal to improve patient access to therapies.
.jpeg "IHW Summit 2026 Highlights Need for Better Rare Disease Care")
India’s rare disease ecosystem took centre stage at the Rare Diseases Action Summit 2026 in New Delhi, organised by the IHW Council, bringing together policymakers, healthcare leaders, patient advocates, industry experts and researchers to discuss so
Aurobindo Pharma said its Unit IV facility operated by APL Healthcare has received a Voluntary Action Indicated (VAI) classification from the U.S. Food and Drug Administration following a recent inspection, indicating minor observations with no regul
.png "India Bans Promotion of Weight-Loss Drugs, Warns Pharma Firms")
India’s drug regulator has barred pharmaceutical companies from promoting weight-loss drugs, warning against direct and surrogate advertising.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")